Adaptive Translational Reprogramming of Metabolism Limits the Response to Targeted Therapy in BRAF^V600 Melanoma

Researchers examined how targeted therapy reprograms metabolism in BRAF-mutant melanoma cells using a genome-wide RNA interference screen and global gene expression profiling.